WHO suspends Covaxin supplies under UN procurement
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Monday
July 04, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
MONDAY, JULY 04, 2022
WHO suspends Covaxin supplies under UN procurement

Coronavirus chronicle

Hindustan Times
03 April, 2022, 10:45 am
Last modified: 03 April, 2022, 11:06 am

Related News

  • Monkeypox cases triple in Europe, WHO says, Africa concerned
  • Turkey records first case of monkeypox
  • More than 3,400 monkeypox cases reported to WHO globally: 5 things to know
  • Monkeypox 'emergency' decision due from WHO sparks African criticism
  • Citizen's initiative declares monkeypox outbreak a 'pandemic', urges WHO action

WHO suspends Covaxin supplies under UN procurement

This suspension is in response to the outcomes of WHO post emergency use listing inspection conducted between 14-22 March, and the need to conduct process and facility upgrade to address recently identified good manufacturing practice (GMP) deficiencies

Hindustan Times
03 April, 2022, 10:45 am
Last modified: 03 April, 2022, 11:06 am
WHO suspends Covaxin supplies under UN procurement

The World Health Organisation (WHO) has suspended the supply of Bharat Biotech's anti-Covid vaccine, Covaxin, under the Covax facility, the UN health body announced on Saturday, attributing it to deficiencies in manufacturing practices.

"The World Health Organisation (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat (Biotech), through UN procurement agencies and recommending to countries that received the vaccine to take actions as appropriate," said WHO in a statement.

This suspension is in response to the outcomes of WHO post emergency use listing inspection conducted between 14-22 March, and the need to conduct process and facility upgrade to address recently identified good manufacturing practice (GMP) deficiencies.

As a result, there will be interruption of supply of Covaxin due to suspension of production for export.

The company, however, has committed to comply by addressing the GMP deficiencies and is developing a corrective and preventive action plan, for submission to the Drugs Controller General of India DCGI and WHO.

Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety

"In the interim and as a precautionary measure, Bharat has indicated its commitment to suspend its production of Covaxin for export," read the statement.

The UN body, however, clarified there were absolutely no issues with the safety and efficacy of the product.

"The risk assessment to date does not indicate change in the risk-benefit ratio. The data, available to WHO, indicate the vaccine is effective and no safety concern exists. For continuation of vaccination with alternative sources of Covid-19 vaccines countries should refer to the respective SAGE recommendation," read the WHO statement.

While the company did not respond to queries on the suspension, in a statement issued on Friday to announce Covaxin for production slow down, it said that it was making appropriate changes in manufacturing processes to match WHO standards.

"…During the recent WHO post EUL inspection, Bharat Biotech agreed with the WHO team on the scope of the planned improvement activities and indicated that they will be executed as soon as practical…," read the Bharat Biotech statement.

"As all existing facilities were repurposed for the manufacture of COVAXIN, with continuous production during the past year, to meet the public health emergency of Covid-19, these upgrades were due. Certain highly sophisticated equipment which were required to enhance the process stringency were unavailable during the Covid-19 pandemic. It has to be stressed that the quality of COVAXIN was never compromised at any point in time."

 

Top News

WHO / COVAXIN

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • China’s new Covid flareup threatens crucial economic region, raising supply chain worries
    China’s new Covid flareup threatens crucial economic region, raising supply chain worries
  • Biman increases flights on domestic routes ahead of Eid
    Biman increases flights on domestic routes ahead of Eid
  • Photo: Collected
    Ex-BCL leader sets himself on fire at Press Club

MOST VIEWED

  • A man helps his son to wear mask at Covid-19 test centre at KSRTC bus stand in Bengaluru.(PTI)
    India records 16,103 new Covid cases, 31 deaths in 24 hours
  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters

Related News

  • Monkeypox cases triple in Europe, WHO says, Africa concerned
  • Turkey records first case of monkeypox
  • More than 3,400 monkeypox cases reported to WHO globally: 5 things to know
  • Monkeypox 'emergency' decision due from WHO sparks African criticism
  • Citizen's initiative declares monkeypox outbreak a 'pandemic', urges WHO action

Features

Last month Swapan Kumar Biswas, the acting principal of Mirzapur United College, was forced to wear a garland of shoes for ‘hurting religious sentiments.’ Photo: Collected

Where do teachers rank in our society?

6h | Panorama
Japanese Ambassador Naoki Ito. Sketch: TBS

'The game-changing projects are in line with the Bay of Bengal Industrial Growth Belt initiative'

9h | Panorama
A Glittery Eid

A Glittery Eid

1d | Mode
Rise’s target customers are people who crave to express themselves through what they wear, and their clothing line is not relegated to any age range.

Level up your Eid game with Rise

1d | Mode

More Videos from TBS

Photo: TBS

Jahangirnagar University protest recent harassment of teachers

3h | Videos
Sanitary Napkin vending machines makes life easier for CU students

Sanitary Napkin vending machines makes life easier for CU students

6h | Videos
Photo: TBS

Covid deaths, cases again on the rise

6h | Videos
Is the Western intention to defeat Russia through Ukraine successful?

Is the Western intention to defeat Russia through Ukraine successful?

19h | Videos

Most Read

1
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

2
TBS Illustration
Education

Universities may launch online classes again after Eid

3
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

4
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

5
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

6
Investor Hiru fined Tk2cr for market manipulation
Stocks

Investor Hiru fined Tk2cr for market manipulation

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Sun Drying Paddy in Monsoon: Workers in a rice mill at Shonarumpur in Ashuganj arrange paddy grains in lumps on an open field to dry out moisture through sunlight. During the rainy season, workers have to take cautions so that the grains do not get wet in the rains. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net